Dear Reader,
WSJ says, "It's the $64 trillion question—will there be a stock market crash soon?" …
Weiss Ratings' research shows the first half of 2026 could be very tough for not all, but certain stocks...
Specifically, a radical shift is about to hit the market …
And it could send some of America's most popular stocks crashing down.
We've identified five stocks you should absolutely avoid as this event plays out …
You'll want to see this list …
And make sure you don't own any of these stocks before the market opens tomorrow …
Because if you hold on to them — it could mean financial ruin.
To find out more about this incoming market shift …
Including the list of five stocks you must absolutely avoid …
Click here now — before it's too late.
Sincerely,
Eliza Lasky,
Weiss Advocate
The 3 Penny Stocks You Swore You'd Never Buy (But You'll Check Anyway)
Submitted by Chris Markoch. Posted: 1/18/2026.
Quick Look
- Vaxart is a clinical-stage biotech developing oral vaccines that could transform global immunization if its platform proves effective.
- Microvision develops cost-effective lidar technology for autonomous vehicles, with upside tied to industry adoption and potential partnerships.
- Datavault AI focuses on monetizing digital data through AI and blockchain tools, offering speculative exposure to the emerging data-as-an-asset theme.
Penny stocks attract speculative investors seeking high-risk, high-reward opportunities. That often means targeting companies with disruptive technologies, those tied to emerging trends, or businesses with compelling turnaround stories. Many of these firms will never survive or scale, but if even one succeeds, investors can see outsized returns.
For investors who believe strength lies in numbers, MarketBeat offers a tool listing the 100 Most Popular Penny Stocks, ranked by the number of MarketBeat subscribers following each company. While subscriber interest is no guarantee of success, it can help build conviction about a stock's potential.
Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company (Ad)
We've found The Next Elon Musk… and what we believe to be the next Tesla.
It's already racked up $26 billion in government contracts.
Peter Thiel just bet $1 Billion on it.
Some investors consider a penny stock any stock trading at $5 or less. The stocks in this screener use the traditional definition: stocks priced below $1. These shares are highly volatile; conduct your own research and understand your risk tolerance before taking a position.
Vaxart: A Potential Game-Changer for Global Immunization Efforts
Vaxart Inc. (NASDAQ: VXRT) is a clinical-stage biotechnology company developing oral vaccines for infectious diseases, including influenza, norovirus and COVID-19. Unlike traditional injectable vaccines, Vaxart's tablet-based platform aims to simplify distribution and improve global accessibility.
The bull case for Vaxart centers on its innovative approach. If the company secures FDA approval and successfully scales, oral vaccines could lower logistical barriers to mass immunization and create significant licensing opportunities. Positive trial results or a commercial collaboration could quickly shift sentiment and valuation given the stock's current low base.
Clinical risk remains the primary challenge. Vaxart has not yet brought a product to market, and vaccine development is costly and unpredictable. Competition from established players with larger R&D budgets also limits visibility. For now, Vaxart is a long-term speculative bet on platform validation rather than near-term profitability.
MarketBeat analyst ratings show only a single analyst covering VXRT, which should give investors pause. The stock has only 18% institutional ownership. On the positive side, VXRT also has relatively low short interest (about 2%), which may help limit some volatility.
Microvision: Developing Cost-Effective LiDAR Units for Autonomous Driving
Microvision Inc. (NASDAQ: MVIS) develops LiDAR (light detection and ranging) sensors used in autonomous vehicles, smart infrastructure and industrial sensing. The company's hardware and software enable precise 3D mapping needed for self-driving systems and advanced driver-assistance systems (ADAS). Microvision focuses on developing compact, cost-effective LiDAR units that could appeal to automakers seeking scalable sensor solutions.
The bull case for Microvision depends on two factors: continued progress toward vehicle automation and potential partnerships with major automakers. If Microvision can demonstrate superior performance or cost advantages, it could land supply agreements or licensing deals that improve revenue visibility. Its technology could also be applied to robotics and smart cities, adding optionality to the growth story.
Despite the promise, Microvision faces stiff competition from LiDAR players like Luminar (NASDAQ: LAZR), Innoviz (NASDAQ: INVZ) and Ouster (NYSE: OUST). The path to profitability is uncertain, and repeated delays in commercial LiDAR adoption continue to frustrate investors.
MVIS is covered by three analysts and carries a consensus price target of $2.50 — a 169% gain from its Jan. 15 closing price. Like many speculative stocks, Microvision has relatively low institutional ownership (around 30%) and high short interest (about 21%), so long-term investors should expect significant volatility.
Datavault AI: Trying to Democratize Data Ownership
Datavault AI Inc. (NASDAQ: DVLT) sits at the intersection of artificial intelligence, data monetization and digital asset management. The company helps organizations turn raw data into tradable, revenue-generating assets through its patented Datavault platform. By combining AI, blockchain and analytics tools, Datavault AI aims to democratize data ownership and unlock monetization opportunities that traditional systems often overlook.
The bullish thesis for Datavault AI is its niche focus and scalability potential. As data becomes an increasingly valuable commodity, businesses and individuals are seeking ways to safely monetize digital information. Datavault's technology could benefit from growing AI adoption and increased focus on data sovereignty. Early-stage traction or strategic partnerships could catalyze investor confidence.
Still, Datavault AI operates in a highly experimental space. The company's business model is evolving, and its path to meaningful revenue is unproven. Institutions own less than 1% of the stock, and short interest is over 16% as of this writing. Investors considering DVLT should treat it as a long-term, speculative position based on belief in data-as-an-asset innovation rather than near-term earnings potential.
This email communication is a sponsored message provided by Weiss Ratings, a third-party advertiser of The Early Bird and MarketBeat.
11780 US Highway 1,
Palm Beach Gardens, FL 33408-3080
Would you like to edit your e-mail notification preferences or unsubscribe from our mailing list?
If you need assistance with your subscription, please feel free to contact our South Dakota based support team at contact@marketbeat.com.
If you no longer wish to receive email from The Early Bird, you can unsubscribe.
Copyright 2006-2026 MarketBeat Media, LLC. All rights protected.
345 North Reid Place, Sixth Floor, Sioux Falls, S.D. 57103. USA..
No comments:
Post a Comment